This page shows the latest drug treatment news and features for those working in and with pharma, biotech and healthcare.
UK biotech company Synairgen has treated the first patient in a phase 3 trial evaluating its potential COVID-19 treatment SNG001. ... Prior to the COVID-19 pandemic, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its
It also addresses the increasing demand across healthcare systems for faster and more flexible treatment solutions,” he added. ... Herceptin has been hit by biosimilar competition, with much of the market share taken from Roche’s drug treatment by
Drug treatment is being investigated in high-risk COVID-19 patients. Abivax’s COVID-19 study evaluating its anti-inflammatory candidate ABX464 has been deemed a ‘research national priority’ by a ... AGE trial with ABX464 drug candidate a research
Prior to the launch of Shionogi's Fetcroja (cefiderocol) in the UK, the drug had already gained European Commission approval earlier this year, and it is the first treatment which protects ... In the US, Shionogi’s drug is approved under the name
The study will investigate and evaluate the efficacy and safety of once-daily oral semaglutide compared to placebo in Alzheimer’s, with an expected main treatment period in the trials of ... disease.”. Alzheimer’s is a notoriously difficult therapy
Within Prevail’s clinical pipeline, PR001 has already scored a US Food and Drug Administration (FDA) fast-track designation for the treatment of PD-GBA patients and nGD. ... It has also been granted an FDA orphan drug designation for the treatment of
More from news
Approximately 0 fully matching, plus 918 partially matching documents found.
treatment or breakthrough drug?
This influx of capital means there are already close to 200 start-ups using AI in drug discovery. ... Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.
Other purposes. The approach can be applied later in the drug development process. ... Gardner concluded: “Many pharmaceutical companies are looking at repurposing: does an approved drug have potential as a treatment for a new condition?
An experimental antiviral: Gilead’s remdesivir. Gilead’s remdesivir, an experimental antiviral drug, is arguably the most-talked about potential treatment for COVID-19. ... The combination drug was first included in Chinese health authorities’
But just as Big Tech has disrupted plenty of other industries, there is every reason to think that it will be interested in the opportunities to move more into drug therapy ... a cool $63bn (which was also notable for putting the world’s best-selling
More from intelligence
Approximately 0 fully matching, plus 47 partially matching documents found.
In his new role he will join Turku-based Faron's executive management team and oversee its drug development strategy, including its clinical programmes for Traumakine and Clevegen. ... Our lead drug candidate Traumakine, for the treatment of Acute
As chief medical officer at Canbex Dr Lledó will lead preparations for proof of concept trials for the company's lead candidate VSN16R, an oral drug intended for the treatment of ... As a practicing neurologist and experienced drug developer, I am very
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
The board certification process for healthcare providers should include an appropriate understanding of the clinical relevance of sex-differences in drug treatment. ... Pharmaceutical companies should pay more attention to sex-appropriate dosing,
Put simply, underrepresentation of anyone - male or female, old or young, and any ethnicities - means that researchers don’t actually know if the treatment or drug they’re investigating works for
To healthcare professionals (HCPs), a patient failing to benefit from drug treatment may require additional consultations, further diagnostic testing, or hospital admission. ... or allied health professionals, who often deliver education, counselling, or
Did you know, for example, that over 3.5 million people in the UK suffer from a rare disease or that 95% of rare diseases don't have an approved treatment ... drug and yet they impact more people than cancer and AIDs combined?
revolution improves our treatment of disease and gives healthcare professionals greater means to identify the most appropriate treatments, the change is proving to be hugely disruptive. ... This will help inform and progress healthcare from
More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.
We love what we do and we think it shows.It shows in the work we do, the space we work...